✦ LIBER ✦

Application of Second Generation Tyrosine Kinase Inhibitors in BCR-ABL Positive Malignancies in the Post-Transplant Period

✍ Scribed by E. Klyuchnikov; O. Osanmaz; P. Schafhausen; S. Asenova; T. Zabelina; F. Ayuk; T. Bruemmendorf; A.R. Zander; N. Kroeger; U. Bacher

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-Generation Tyrosine Kinase Inhibi

✍ Klyuchnikov, Evgeny; Schafhausen, Philippe; Kröger, Nicolaus; Brummendorf, 📂 Article 📅 2009 🏛 S. Karger AG 🌐 English ⚖ 136 KB

A neuropharmacokinetic assessment of baf

✍ Portnow, Jana; Badie, Behnam; Markel, Susan; Liu, An; D’Apuzzo, Massimo; Frankel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 374 KB

The in vitro activity of the tyrosine ki

✍ Liu, W M; Stimson, L A; Joel, S P 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Drug resistance and BCR-ABL kinase domai

✍ Soverini, Simona; De Benedittis, Caterina; Papayannidis, Cristina; Paolini, Stef 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

BCR-ABL1 transcript at 3 months predicts

✍ Kim, Dennis D.; Lee, Honggi; Kamel-Reid, Suzanne; Lipton, Jeffrey H. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB